Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Darling Joseph G
   2. Issuer Name and Ticker or Trading Symbol
CONMED CORP [CNMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President ConMed Linvatec
(Last)
(First)
(Middle)
C/O LINVATEC CORP., 11311 CONCEPT BLVD.		 3. Date of Earliest Transaction (Month/Day/Year)
06/01/2012
(Street)

LARGO, FL 33773		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/01/2012   M   1,500 A $ 0 2,473 D  
Common Stock 06/01/2012   F   397 D $ 26.09 2,076 D  
Common Stock 06/01/2012   M   800 A $ 0 2,876 D  
Common Stock 06/01/2012   F   212 D $ 26.09 2,664 D  
Common Stock 06/01/2012   M   800 A $ 0 3,464 D  
Common Stock 06/01/2012   F   212 D $ 26.09 3,252 D  
Common Stock 06/01/2012   M   800 A $ 0 4,052 D  
Common Stock 06/01/2012   F   212 D $ 26.09 3,840 D  
Common Stock 06/01/2012   M   2,100 A $ 0 5,940 D  
Common Stock 06/01/2012   F   556 D $ 26.09 5,384 D  
Common Stock 06/01/2012   F   529 D $ 26.09 4,855 D  
Common Stock 06/01/2012   M   2,000 A $ 0 6,855 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Rsus (restricted Stock Units) $ 0 06/01/2012   M     1,500   (1) 06/01/2018 Common Stock 1,500 $ 0 1,500 D  
Rsus (restricted Stock Units) $ 0 06/01/2012   M     800   (2) 06/01/2019 Common Stock 800 $ 0 1,600 D  
Rsus (restricted Stock Units) $ 0 06/01/2012   M     800   (2) 06/01/2020 Common Stock 800 $ 0 2,400 D  
Rsus (restricted Stock Units) $ 0 06/01/2012   M     800   (2) 06/01/2021 Common Stock 800 $ 0 3,200 D  
Rsus (restricted Stock Units) $ 0 06/01/2012   M     2,100   (3) 07/29/2021 Common Stock 2,100 $ 0 12,900 D  
Rsus (restricted Stock Units) $ 0 06/01/2012   A   4,000     (2) 06/01/2022 Common Stock 4,000 $ 0 4,000 D  
Sars (Stock Appreciation Rights) $ 26.09 06/01/2012   A   10,000     (4) 06/01/2022 Common Stock 10,000 $ 0 10,000 D  
PSUs (Performance Stock Units) $ 0 06/01/2012   A   10,000     (5) 06/01/2021 Common Stock 10,000 $ 0 10,000 D  
PSUs (Performance Stock Units) $ 0 06/01/2012   M     2,000   (5) 06/01/2021 Common Stock 2,000 $ 0 8,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Darling Joseph G
C/O LINVATEC CORP.
11311 CONCEPT BLVD.
LARGO, FL 33773		       President ConMed Linvatec  

Signatures

 Daniel S. Jonas for Joseph G. Darling by Power of Attorney   06/05/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
(2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
(3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year starting June 1, 2012 and 15% vesting in the sixth and seventh year.
(4) The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
(5) Each performance share unit (PSU) represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long- Term Incentive Plan, with the PSUs generally vesting over a five year period. The performance share units vest upon the achievement of performance goals.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.